Lebwohl David 的 Form 4 申報
Intellia Therapeutics, Inc.（NTLA），2021/11/9 申報
- 申報編號
- 0001209191-21-063698
- 申報時間
- 2021/11/9
- 交易日
- 2021/11/5
- 申報延遲
- 4 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 5 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $31.9 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Lebwohl DavidCIK 0001810882 | 高階主管（執行副總裁、醫療長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/11/5 | Common Stock | M行使選擇權取得 | +2,400 | $12.62 | +$30,288 | 11,114 | 直接 | |
| 2021/11/5 | Common Stock | S賣出處分 | −1,200 | $131.71F2 | −$158,052 | 9,914 | 直接 | |
| 2021/11/5 | Common Stock | S賣出處分 | −452 | $132.62F3 | −$59,944.24 | 9,462 | 直接 | |
| 2021/11/5 | Common Stock | S賣出處分 | −548 | $134.07F4 | −$73,470.36 | 8,914 | 直接 | |
| 2021/11/5 | Common Stock | S賣出處分 | −200 | $135.34 | −$27,068 | 8,714 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/11/5 | Common Stock | M行使選擇權處分 | −2,400 | $0.00 | $0 | 180,077 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.36 to $132.055, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 5, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.42 to $133.32, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 5, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.79 to $134.67, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 5, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。